AcedrA is part of : - The United Nations Global Compact - The Global Alliance for Genomics & Health - Saudi Vision 2030 A specialized company dedicated in operating in unmet medical & commercial needs for contributing to the patient care in Middle East & Africa. AcedrA is a KSA Based Company focused on Marketing & Distribution of Pharmaceuticals & Biotechonlogy of Niche Therapeutic Segments Novel Portfolios: Rare Diseases, Orphan Drugs, Hematology, Oncology, Metabolic Diseases, Genetic Disorders, Enzyme Replacement Therapies, Recombinant Technologies, Life Threatening Conditions Medicines, Neurology, Biosimilairs AcedrA will have to successfully introduce “New to Market” and “New in Class” products to the Middle East & Africa markets. These introductions will be done in full coordination with our future & potential partners. Its expansion is in the Middle East, Turkey, and Africa Region, aiming to be the leading specialty pharmaceutical company by putting robust milestones for new therapies in those markets and shaping the future of many existing therapeutic areas. AcedrA is managed by high skilled & competent leaders with average experience of 22 years in the region.